STOCKWATCH
·
Pharmaceuticals
Acquisitions30 Jun 2025, 04:21 pm

Aurobindo Pharma delays 26% stake acquisition in Swarnaakshu Solar Power due to state government approval

AI Summary

Aurobindo Pharma Ltd. has announced a delay in its acquisition of a 26% stake in Swarnaakshu Solar Power Private Limited. The initial plan was to complete the acquisition and set up a captive solar power plant by June 30, 2025. However, due to pending state government approval for setting up the captive solar power plant, the required investment for the 26% stake acquisition will now be completed on or before September 30, 2025, subject to the receipt of approval from the concerned state government.

Key Highlights

  • Aurobindo Pharma delays 26% stake acquisition in Swarnaakshu Solar Power due to state government approval
  • The initial plan was to complete the acquisition and set up a captive solar power plant by June 30, 2025
  • The required investment for the 26% stake acquisition will now be completed on or before September 30, 2025
  • The delay is due to pending state government approval for setting up the captive solar power plant
  • The acquisition is subject to the receipt of approval from the concerned state government
AUROPHARMA
Pharmaceuticals
AUROBINDO PHARMA LTD.

Price Impact